NW-3-237

N/A

Report date: 2025/03/04 17:06:18
NME

Base Information

Drug NameNW-3-237
Drug Alias NameNW-3-237
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitors
TargetsSerine-protein kinase ATR
Therapy Area/IndicationsNeoplasm MetastasisBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNewave Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesNewave Pharmaceutical IncGuangzhou Lupeng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisBrain Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A